Article | Country | Case data source | Exclusions | MLEA definition | Standardisation | Statistic | Study period | Statistic value (95% CI where available) | |
General population | |||||||||
Ahmad et al29 | England | HES | Age <50 and >84 years | Proximal to the ankle | Age | Incidence proportion | 2003–2008* | 26 | |
Ahmad et al10 | England | HES | Age <50 and >84 years | Proximal to the ankle | Age | Incidence proportion | 2003–2008* | 26.3 (26 to 26.6) | |
Ahmad et al7 | England | HES | Age <50 and >84 years | Proximal to the ankle | Age | Incidence proportion | 2003* 2004* 2005* 2006* 2007* 2008* 2009* 2010* 2011* 2012* | 27.7 27.7 26.6 25.3 26.0 26.8 25.3 25.1 23.7 22.9 | |
Ambler et al30 | UK | NVR | None | BKA/TKA/AKA/hip disarticulation/hind quarter | N/A | Number | 2014–2016 | 9549 | |
Behrendt et al4 | England | HES | Trauma, cancer | Proximal to the ankle | None | Incidence proportion (PAD related amputations) | 2010 2011 2012 2013 2014 | 9.5 9.1 8.6 8.7 8.2 | |
Kennon et al 37 | Scotland | SMR01 | Trauma, cancer | Through/proximal to the ankle | None | Incidence proportion (Diabetes related amputations) | 2004 2005 2006 2007 2008 | 6.73 (6.06 to 7.49) 5.06 (4.48 to 5.72) 5.28 (4.68 to 5.94) 5.05 (4.48 to 5.71) 4.43 (3.89 to 5.04) | |
Moxey et al 9 | England | HES | None | BKA/TKA/AKA | None | Incidence proportion | 2003–2007* | 51.1 | |
Moxey et al 38 | England | HES | Age <50 and >84 years, trauma, cancer | BKA/TKA/AKA | N/A | Number | 2002–2005* | 14 168 | |
Nickinson et al 39 | England | HES linked CPRD | Age <17 years, trauma, cancer | Proximal to the ankle | N/A | Number | 2000 – 2016 | 3260 | |
NVR report 201546 | UK | NVR | Bilateral | BKA/AKA | N/A | Number | 2014 | 2465 | |
NVR report 201647 | UK | NVR | Trauma, bilateral MLEA | BKA/AKA | N/A | Number | 2014–2015 | 5318 | |
NVR report 201748 | UK | NVR | Trauma, bilateral MLEA | BKA/AKA | N/A | Number | 2014–2016 | 8866 | |
NVR report 201849 | UK | NVR | Trauma, bilateral MLEA | BKA/AKA | N/A | Number | 2015–2017 | 9293 | |
NVR report 201922 | UK | NVR | Trauma, bilateral MLEA | BKA/AKA | N/A | Number | 2016–2018 | 9508 | |
NVR report 202040 | UK | NVR | Trauma, bilateral MLEA | BKA/TKA/AKA | N/A | Number | 2017–2019 | 10 022 | |
Staniszewska et al 42 | England | HES | None | ‘Major amputation' not further defined | N/A | Number | 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 | 5418 5334 5208 4864 4881 4804 4542 4829 4973 4994 5004 4638 4608 4526 4473 4573 4735 4742 4907 | |
Vamos et al44 | England | HES | Trauma | Through/proximal to the ankle | None | Incidence proportion (people without diabetes†) | 2004* 2005* 2006* 2007* 2008* | 7.7 7.5 6.8 7.1 6.9 | |
Vamos et al 45 | England | HES | Trauma | Through/proximal to the ankle | Age, sex | Incidence proportion (people without diabetes†) | 1996* 1997* 1998* 1999* 2000* 2001* 2002* 2003* 2004* 2005* | 7.0 6.8 6.8 6.7 6.2 6.2 5.7 5.4 5.1 4.9 | |
Population with diabetes | |||||||||
Gunn et al 31 | England | HES, CPRD | Age <18 years, previous LEA, non-type 2 diabetes, censored prior to 1 April 2011 | ‘Major amputation’ defined by code list | None | Incidence rate | 2010–2017* | Type 2 diabetes 96 | |
Holman et al 8 | England | HES | Age <17 years | Proximal to the ankle | None | Incidence rate | 2007–2009* | 99 | |
Kennon et al 37 | Scotland | SMR01 | Trauma, cancer | Through/proximal to the ankle | None | Incidence proportion | 2004 2005 2006 2007 2008 | 187 (168 to 207) 134 (119 to 151) 135 (120 to 152) 126 (112 to 142) 111 (99 to 126) | |
NDA 2009–2 0143 | England | HES | None | ‘Major amputation' not further defined | None | Incidence proportion | 2009* | 70 | |
NDA 2010–2 0132 | England and Wales | HES, PEDW | None | BKA/TKA/AKA | Age, sex | Incidence proportion | 2010* | 291 | |
NDA 2011–2 0133 | England and Wales | HES, PEDW | None | BKA/TKA/AKA | None | Incidence proportion | 2010–2011* | 170 | |
NDA 2012–2 0134 | England and Wales | HES, PEDW | None | BKA/TKA/AKA | None | Incidence proportion | 2012* | 70 | |
NDA 2015–2 0136 | England and Wales | HES, PEDW | None | ‘Major amputation' not further defined | None | Incidence proportion | 2015* | 75 | |
NDA 2017–2 0135 | England and Wales | HES, PEDW | None | ‘Major amputation' not further defined | None | Incidence proportion | 2017* | 73 | |
PHE Fingertips 202041 | England | HES | Age <17 years | Proximal to the ankle | Age, ethnicity | Incidence proportion (/rate)‡ | 2017–2019* | 82 (81 to 84) | |
Vamos et al 44 | England | HES | Trauma | Through/proximal to the ankle | None | Incidence proportion | 2004* 2005* 2006* 2007* 2008* | 118 106 97 100 102 | |
Vamos et al 45 | England | HES | Trauma | Through/proximal to the ankle | Age, sex | Incidence proportion | 1996* 1997* 1998* 1999* 2000* 2001* 2002* 2003* 2004* 2005* | Type 1 diabetes 1.3 1.4 1.5 1.4 1.1 1.2 1.1 0.9 0.9 0.7 | Type 2 diabetes 2.0 2.1 2.1 2.3 2.3 2.4 2.6 2.6 2.7 2.7 |
Statistic value is presented as incidence proportion per 100 000 population, incidence rate per 100 000 person years or total number where a calculated statistic was not reported. If both standardised and crude values were available, the standardised value has been presented. Where outcome measures were given for the population with diabetes by type, these are specified in the table.
*Study period conducted over the financial year (April–March) rather than the calendar year.
†Incidence proportion of people without diabetes rather than the general population (which includes those with diabetes).
‡Statistic definition unclear in report.
AKA, above knee amputation; BKA, below knee amputation; CPRD, clinical practice research datalink; HES, Hospital Episode Statistics; LEA, lower extremity amputation (minor and major); NDA, National Diabetes Audit; NVR, National Vascular Registry; PEDW, Patient Episode Database for Wales; PHE, Public Health England; SMR01, Scottish morbidity records; TKA, through knee amputation.